carbamates has been researched along with Diabetic Nephropathies in 8 studies
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
Excerpt | Relevance | Reference |
---|---|---|
"Repaglinide has a good safety and efficacy profile in type 2 diabetic patients complicated by renal impairment and is an appropriate treatment choice, even for individuals with more severe degrees of renal impairment." | 2.71 | Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function. ( Hasslacher, C, 2003) |
"Diet or tablet-treated patients with Type 2 diabetes (n = 256; age 40-75 years, body mass index (BMI) 20-35 kg/m2, HbA1c 4." | 2.70 | Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study. ( Dejgaard, A; Kilhovd, B; Lager, I; Madsbad, S; Mustajoki, P, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delanghe, S | 1 |
Moerman, A | 1 |
Pletinck, A | 1 |
Schepers, E | 1 |
Glorieux, G | 1 |
Van Biesen, W | 1 |
Delanghe, JR | 1 |
Speeckaert, MM | 1 |
del Pozo-Fernández, C | 1 |
Pardo-Ruiz, C | 1 |
Sánchez-Botella, C | 1 |
Blanes-Castañer, V | 1 |
López-Menchero, R | 1 |
Gisbert-Sellés, C | 1 |
Sánchez-Jodar, C | 1 |
Alvarez-Avellán, L | 1 |
Hasslacher, C | 1 |
Kraus, LM | 1 |
Kraus, AP | 1 |
Madsbad, S | 1 |
Kilhovd, B | 1 |
Lager, I | 1 |
Mustajoki, P | 1 |
Dejgaard, A | 1 |
Camerini-Davalos, RA | 3 |
Reddi, AS | 3 |
Ehrenreich, TH | 1 |
Strugatz, LH | 1 |
Oppermann, W | 3 |
Chen, M | 1 |
Velasco, CA | 1 |
1 review available for carbamates and Diabetic Nephropathies
Article | Year |
---|---|
Carbamoylation of amino acids and proteins in uremia.
Topics: Amino Acids; Animals; Carbamates; Cyanates; Diabetic Nephropathies; Enzymes; Glucose; Hormones; Huma | 2001 |
2 trials available for carbamates and Diabetic Nephropathies
Article | Year |
---|---|
Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function.
Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; | 2003 |
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 2; Diabetic Nephropathies | 2001 |
5 other studies available for carbamates and Diabetic Nephropathies
Article | Year |
---|---|
Quantification of carbamylated albumin in serum based on capillary electrophoresis.
Topics: Adult; Aged; Carbamates; Diabetic Nephropathies; Electrophoresis, Capillary; Female; Humans; Male; M | 2017 |
Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
Topics: Acidosis, Lactic; Aged; Carbamates; Consensus Development Conferences as Topic; Contraindications; D | 2012 |
Diabetic glomerulosclerosis in KK mice and its prevention by glyburide and pyridinolcarbamate.
Topics: Animals; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose | 1979 |
Diabetic microangiopathy in KK mice. IV. Effect of pyridinolcarbamate on kidney glucosyltransferase activity and glomerulosclerosis.
Topics: Animals; Carbamates; Diabetic Nephropathies; Glucosyltransferases; Kidney; Kidney Cortex; Mice; Pyri | 1978 |
Diabetic microangiopathy in KK mice. II. Suppression of Glomerulosclerosis by pyridinolcarbamate.
Topics: Animals; Body Weight; Carbamates; Diabetic Nephropathies; Drug Evaluation, Preclinical; Glucose; Glu | 1977 |